Free Trial

Lineage Cell Therapeutics (LCTX) Insider Trading & Ownership

Lineage Cell Therapeutics logo
$0.56 +0.06 (+11.16%)
(As of 12/20/2024 05:45 PM ET)

Lineage Cell Therapeutics (NYSEAMERICAN:LCTX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
26.60%
Number Of
Insiders Buying
(Last 12 Months)
4
Amount Of
Insider Buying
(Last 12 Months)
$7.14 M
Number Of
Insiders Selling
(Last 12 Months)
0
Get LCTX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Lineage Cell Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

LCTX Insider Buying and Selling by Quarter

Lineage Cell Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/21/2024Brian M CulleyCEOBuy40,000$0.60$24,000.00  
8/16/2024Jill Ann HoweCFOBuy10,500$0.89$9,345.00  
5/24/2024Brian M CulleyCEOBuy10,000$1.05$10,500.00  
2/8/2024Don M BaileyDirectorBuy96,155$1.04$100,001.20  
2/6/2024Broadwood Partners, L.P.DirectorBuy6,730,770$1.04$7,000,000.80  
(Data available from 1/1/2013 forward)

LCTX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Lineage Cell Therapeutics includes Brian M Culley, Broadwood Partners, L.P., Dipti Amin, Don M Bailey, Gary S Hogge, Jill Ann Howe, and Michael H Mulroy. Learn more on insiders at LCTX.

26.60% of Lineage Cell Therapeutics stock is owned by insiders. Learn more on LCTX's insider holdings.

The following insiders have purchased LCTX shares in the last 24 months: Brian M Culley ($34,500.00), Broadwood Partners, L.P. ($7,000,000.80), Don M Bailey ($100,001.20), and Jill Ann Howe ($9,345.00).

Insiders have purchased a total of 6,887,425 LCTX shares in the last 24 months for a total of $7,143,847.00 bought.

Lineage Cell Therapeutics Key Executives

  • Mr. Brian M. Culley M.A. (Age 53)
    M.B.A., CEO, President & Director
    Compensation: $986.7k
    1 recent trades
  • Ms. Jill Ann Howe (Age 47)
    CFO & Principal Financial and Accounting Officer
    Compensation: $587.4k
    1 recent trades
  • Mr. George A. Samuel III (Age 43)
    J.D., General Counsel & Company Secretary
    Compensation: $554.51k
  • Ioana C. Hone
    Director of Investor Relations
  • Dr. Charlotte Hubbert Ph.D.
    Vice President of Corporate Development
  • Ms. Brandi L. Roberts CPA (Age 50)
    M.B.A., Consultant
    Compensation: $407.45k
  • Mr. William Annett MBA (Age 70)
    President & CEO of OncoCyte Corporation
    Compensation: $53.2k
  • Dr. Rami Skaliter Ph.D. (Age 66)
    Chief Executive Officer of Cell Cure Neurosciences
  • Ms. Alexandra Hernandez
    Senior Director of Finance & Controller
  • Dr. Harold D. Waitz (Age 82)
    Vice President of Regulatory Affairs & Quality Control
    Compensation: $90k


This page (NYSEAMERICAN:LCTX) was last updated on 12/21/2024 by MarketBeat.com Staff
From Our Partners